Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Clinical trial NCT03704714 · SUSPENDED

Trial details

NCT number: NCT03704714
Sponsor: Northwestern University
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Aggressive Non-Hodgkin Lymphoma B-Cell Non-Hodgkin Lymphoma CD20 Positive Diffuse Large B-Cell Lymphoma Unclassifiable Intravascular Large B-Cell Lymphoma Primary Mediastinal (Thymic) Large B-Cell Lymphoma T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

Start date: 2018-11-20
Primary completion: 2024-12-11
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.